Moderna has become a well-known name thanks to its highly effective COVID-19 vaccine, based on mRNA technology.But even before the pandemic hit, the company was developing an mRNA-based vaccine against another scourge, respiratory syncytial virus (RSV), which primarily affects infants and the elderly.
#people #development #combination #massachusetts #effectiveness #young-children #pandemic-hit #hospitalizations #remote-learning #chief-medical-officer
[
add
]
[
|
|
...
]